Practical guidance on the use of SGLT2 inhibitors in patients with T2D during Ramadan

This module summarises current practical guidance, evidence and recommendations on the use of SGLT2 inhibitors in patients with T2D before, during and after Ramadan.

Practical guidance on the use of SGLT2 inhibitors in patients with T2D during Ramadan
Rate this content
  • Practical guidance on the use of SGLT2 inhibitors in patients with T2D during Ramadan
  • SGLT2 inhibitors and Ramadan in patients with T2D
  • SGLT2 inhibitors and Ramadan in patients with T2D
  • The prevalence of diabetes is high and increasing rapidly in Muslim-majority countries
  • Fasting during the holy month of Ramadan forms one of the five pillars of the Muslim faith
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go